You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 14, 2026

Generic Companies with Tentative Approvals for: Cipla

✉ Email this page to a colleague

Cipla Generic Filers with Tentative Approvals

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Generic Name	NDA	Strength	Dosage Form
Cipla Ltd	rifaximin	219570	200MG	TABLET
Cipla Ltd	bictegravir, emtricitabine and tenofovir alafenamide	218766	15MG	TABLET
Cipla Ltd	lamivudine; nevirapine; zidovudine	203076	30MG; 50MG; 60MG	TABLET; ORAL SUSPENSION
Cipla Limited	efavirenz; emtricitabine; tenofovir disoproxil fumarate	091593	200MG	TABLET; ORAL
Cipla Limited	lamivudine	077980	10MG/ML	SOLUTION; ORAL
Cipla	darunavir	206288	400MG	TABLET;ORAL
Cipla Limited	efavirenz	077916	600MG	TABLET; ORAL
>Applicant	>Generic Name	>NDA	>Strength	>Dosage Form

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.